Bill And Melinda Gates Foundation Bill And Melinda Gates Foundation [Member] Bill And Melinda Gates Foundation [Member] Proceeds from warrant exercises Proceeds from Warrant Exercises Supplemental disclosure of non-cash investing and financing activities: Supplemental Cash Flow Information [Abstract] Customer [Domain] Customer [Domain] Federal statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Right-of-use asset Operating Lease, Right-of-Use Asset Risks and Uncertainties [Abstract] Microchips Biotech, Inc. Microchips Biotech, Inc. [Member] Microchips Biotech, Inc. [Member] Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Accrued compensation and benefits expenses Employee-related Liabilities, Current Purchase agreement Deferred Offering Costs Income Statement Location [Axis] Income Statement Location [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Going Concern Liquidity [Policy Text Block] Liquidity Cost, maintenance Cost, Maintenance Segment Reporting Segment Reporting, Policy [Policy Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Settlement of contingent closing consideration liability with stock issuance in connection with acquisition of business Payment for Contingent Consideration Liability, Financing Activities Additional paid-in capital Additional Paid in Capital, Common Stock Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Operating lease weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Additional potential grant funding Additional Potential Funding Related To Grant Award Additional Potential Funding Related To Grant Award Warrants exercised (in shares) Number Of Common Stock Warrants Exercised Number of common stock warrants exercised. Other non-current assets Total other non-current assets Other Assets, Noncurrent Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] License And Collaboration Agreement License And Collaboration Agreement [Member] License And Collaboration Agreement [Member] Amended And Restated Two Thousand Fourteen Stock Incentive Plan Amended And Restated Two Thousand Fourteen Stock Incentive Plan [Member] Amended And Restated Two Thousand Fourteen Stock Incentive Plan [Member] Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Milestone payment paid in common stock Milestone payments Milestone Payments, Contingent Amount Milestone payments, contingent amount. Weighted- Average Remaining Contractual Life (Years) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Roll Forward Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term roll forward. Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity File Number Entity File Number Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Business development Business Development Hammock Pharmaceuticals, Inc. Hammock Pharmaceuticals, Inc. [Member] Hammock Pharmaceuticals, Inc. [Member] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Organization, Consolidation and Presentation of Financial Statements [Abstract] Other Current Assets Other Current Assets [Member] Prior year - additions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Research and development Research and Development Expense [Member] Sale of Stock [Axis] Sale of Stock [Axis] Subsequent Events [Abstract] Subsequent Events [Abstract] Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Cash and Cash Equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Potential annual license maintenance fee, payments in year one Potential Annual License Maintenance Fee, Payments In Year One Potential Annual License Maintenance Fee, Payments In Year One Grant, DARE-PTB1 Grant, DARE-PTB1 [Member] Grant, DARE-PTB1 Equity Award [Domain] Award Type [Domain] Local Phone Number Local Phone Number Assets Assets [Abstract] Options exercisable, ending (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Options vested and expected to vest, ending (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Concentration risk percentage Concentration Risk, Percentage Cash and cash equivalents Business Combination Reverse Merger Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents Business combination reverse merger recognized identifiable assets acquired and liabilities assumed cash and equivalents. Preferred stock issued Preferred Stock, Value, Issued Stock options outstanding (in shares) Outstanding beginning balance (in shares) Outstanding ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Accumulated Deficit Retained Earnings [Member] Regular Repurchase (in shares) Regular Repurchase, Common Stock Issuable Regular Repurchase, Common Stock Issuable Operating lease assets Operating Lease, Right-Of-Use Asset, Noncurrent Operating Lease, Right-Of-Use Asset, Noncurrent Project Project [Domain] Related Party [Axis] Related Party [Axis] Private Dare Private Dare [Member] Private Dare. Right to develop period License Agreement, Right To Develop, Period License Agreement, Right To Develop, Period Operating right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Summary of Major Components of Company's Deferred Tax Assets Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] 2018 ATM Sales Agreement 2018 At The Market Sales Agreement [Member] 2018 At The Market Sales Agreement Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Number of operating segments Number of Operating Segments Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Loss per common share - basic (in usd per share) Earnings Per Share, Basic Contingent consideration Business Combination, Contingent Consideration, Liability, Current Operating loss carryforward, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Payment to be received upon termination without cause Employment Agreement, Salary Payment Received Upon Termination Without Cause Employment Agreement, Salary Payment Received Upon Termination Without Cause Unamortized stock-based compensation expense Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent Sales Milestones Sales Milestones [Member] Sales Milestones [Member] Payment to be received upon termination for cause or for good reason Employment Agreement, Salary Payment Received Upon Termination for Cause or Good Reason Employment Agreement, Salary Payment Received Upon Termination for Cause or Good Reason Prepaid expenses Total prepaid expenses Prepaid Expense, Current Research and development agreement, commitment, amount Research and Development Agreement, Commitment, Amount Research and Development Agreement, Commitment, Amount Transfers out of Level 3 Asset Acquisition, Consideration Transferred, Contingent Consideration Net proceeds from issuance of common stock Net Proceeds From Issuance Of Common Stock And Warrants Net Proceeds From Issuance Of Common Stock And Warrants Operating lease, payments Operating Lease, Payments Options to purchase number of outstanding shares of common stock (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Upon Achieving Certain Commercial Milestones Upon Achieving Certain Commercial Milestones [Member] Upon Achieving Certain Commercial Milestones [Member] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Aggregate commission rate Percentage Of Aggregate Commission Percentage of aggregate commission. Registration payment arrangement, maximum potential consideration Registration Payment Arrangement, Maximum Potential Consideration Entity Voluntary Filers Entity Voluntary Filers Plan Name [Axis] Plan Name [Axis] CRADA CRADA [Member] CRADA Deemed dividend from trigger of round down provision feature Deemed dividend from trigger of down round provision Deemed Dividend From Trigger Of Round Down Provision Feature Deemed Dividend From Trigger Of Round Down Provision Feature Level 1 Fair Value, Inputs, Level 1 [Member] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Entity Small Business Entity Small Business Other Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent Current year - increases Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Total liabilities and stockholders' equity (deficit) Liabilities and Equity Accrued clinical and related expenses Other Accrued Liabilities, Current Upon Achieving Certain Clinical And Regulatory Development Milestones Upon Achieving Certain Clinical And Regulatory Development Milestones [Member] Upon Achieving Certain Clinical And Regulatory Development Milestones [Member] Commitments and Contingencies Commitments Disclosure [Text Block] Exercised (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Concentration Risk [Line Items] Concentration Risk [Line Items] Liabilities and stockholders’ equity (deficit) Liabilities and Equity [Abstract] Sales based milestones amount Milestone Payments, Contingent Amount, Sales Based Milestones Amount Milestone Payments, Contingent Amount, Sales Based Milestones Amount Accounts payable Increase (Decrease) in Accounts Payable Total accrued expenses Accounts Payable and Accrued Liabilities, Current Operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Operating expenses Operating Expenses [Abstract] Entity Interactive Data Current Entity Interactive Data Current Research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Stock options exercised Stock Issued During Period, Value, Stock Options Exercised Current portion of contingent consideration Asset Acquisition, Contingent Consideration, Noncurrent Asset Acquisition, Contingent Consideration, Noncurrent Minimum Minimum [Member] Bayer Healthcare License Agreement Bayer Healthcare License Agreement [Member] Bayer Healthcare License Agreement [Member] Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Non-cash loss on settlement of contingent liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Balance Sheet Location [Domain] Balance Sheet Location [Domain] Square feet of office space Net Rentable Area Proceeds from issuance of note payable Proceeds from Notes Payable Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Unrecognized tax benefits Beginning uncertain tax benefits Ending uncertain tax benefits Unrecognized Tax Benefits Income Tax Authority Income Tax Authority [Domain] Total deferred tax assets Deferred Tax Assets, Gross Prepaid insurance, long-term portion Prepaid Insurance Noncurrent Prepaid insurance noncurrent. Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Address, State or Province Entity Address, State or Province License agreement, termination period due to performance failure License Agreement Termination Period Due To Performance Failure License agreement, termination period due to performance failure. Current Liabilities Liabilities, Current [Abstract] Issuance of common stock, net of issuance costs Stock Issued During Period, Value, New Issues General and administrative General and Administrative Expense Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Options exercisable, ending (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Summary of Components of Loss from Continuing Operations Before Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Stock-based Compensation Share-based Payment Arrangement [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Accrued indemnification P\provisions Accrued Indemnification Provisions Accrued indemnification provisions. Leases Lessee, Leases [Policy Text Block] Accrued interest or penalties recorded related to uncertain tax positions Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Accounting Policies [Abstract] Accounting Policies [Abstract] Asset acquisition, contingent consideration, beginning balance Asset acquisition, contingent consideration, ending balance Contingent consideration Asset Acquisition, Contingent Consideration Asset Acquisition, Contingent Consideration Outstanding, ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Recognized offering expenses Payments of Stock Issuance Costs Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues Accrued legal and professional expenses Accrued Professional Fees, Current Total operating lease liabilities Operating Lease, Liability Letter of credit related to lease of real property Letters of Credit Outstanding, Amount Document Transition Report Document Transition Report Warrants Expiring on April 4, 2026 Warrants Expiring On April Four Two Thousand Twenty Six [Member] Warrants expiring on april four two thousand twenty six. Common stock: $0.0001 par value, 120,000,000 shares authorized, 83,944,119 and 41,596,253 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively Common stock, value, issued Common Stock, Value, Issued Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments and contingencies. Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Commitments and contingencies Commitments and Contingencies Subsequent Event [Table] Subsequent Event [Table] Leased Properties Lessee, Operating Leases [Text Block] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Receivables [Abstract] Receivables [Abstract] Accounting Standards Update 2017-11 Accounting Standards Update 2017-11 [Member] Summary of Assumptions Used in Black-Scholes Option-Pricing Model for Stock Options Granted to Employees, and Non-Employee Directors Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and contingencies. Schedule of Other Non-Current Assets Schedule of Other Assets, Noncurrent [Table Text Block] Working capital increase Working Capital Increase (Deficit) Working Capital Increase (Deficit) Legal Entity [Axis] Legal Entity [Axis] Prepaid clinical expense Prepaid Clinical Expense Prepaid Clinical Expense Auditor Name Auditor Name Cover [Abstract] Class of Stock [Axis] Class of Stock [Axis] Offering expenses Offering Expenses Offering Expenses Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Shares underlying outstanding warrants (in shares) Class of Warrant or Right, Outstanding Royalty term Royalty Agreement, Term Royalty Agreement, Term Loan under Paycheck Protection Program Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received Coronavirus Aid, Relief, and Economic Security Act, Loan Proceeds Received Less: accreted interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Major Vendor Major Vendor [Member] Major Vendor Income Tax Authority Income Tax Authority [Axis] Entity [Domain] Entity [Domain] Equity issued in consideration of acquisition (in shares) Common stock issued to microchips capital stock holders (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Accrued expenses Accrued Liabilities, Current 2014 Employee Stock Purchase Plan Two Thousand And Fourteen Employee Stock Purchase Plan [Member] Two thousand and fourteen employee stock purchase plan. Revenue from grant for notice of awards Revenue from Contract with Customer, Excluding Assessed Tax Stock compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross Stock Options Share-based Payment Arrangement, Option [Member] Prepaid expenses Increase (Decrease) in Prepaid Expense Equity [Abstract] Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating loss carryforwards not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Amortized weighted average period Weighted Average Amortization Period Weighted Average Amortization Period Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Common stock Common Stock [Member] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Loss from operations Operating Income (Loss) Defined contribution plan, employer matching contributions Defined Contribution Plan, Employer Discretionary Contribution Amount Current portion of lease liabilities Operating Lease, Liability, Current Basis of Presentation and Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Health coverage to be received upon termination without cause Employment Agreement, Health Benefits Coverage Received Upon Termination Without Cause Employment Agreement, Health Benefits Coverage Received Upon Termination Without Cause Strategic Agreements Collaborative Arrangement Disclosure [Text Block] SST Strategic Science And Technologies D Limited Liability Company And Strategic Science Technologies Limited Liability Company [Member] Strategic Science and Technologies-D, LLC and Strategic Science Technologies, LLC. Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Change in control of company, termination without cause or resignation for good reason, period Employment Agreement, Change In Control Of Company, Termination Without Cause Or Resignation For Good Reason Employment Agreement, Change In Control Of Company, Termination Without Cause Or Resignation For Good Reason, Period Stock-based compensation Share-based Payment Arrangement, Noncash Expense Additional Paid-in Capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Depreciation Depreciation Extension lease term Lessee, Operating Lease, Extension Term Lessee, Operating Lease, Extension Term Accrued expenses Increase (Decrease) in Accrued Liabilities Milestone payments Research And Development Milestone Payment Research and development milestone payment. Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Grant, Ovaprene Grant, Ovaprene [Member] Grant, Ovaprene 2015 Stock Incentive Plan Two Thousand And Fifteen Stock Incentive Plan [Member] Two Thousand And Fifteen Stock Incentive Plan [Member] Capitalized research and development costs Deferred Tax Assets Capitalized Research And Development Cost Deferred Tax Assets Capitalized Research And Development Cost Deferred grant funding Deferred Grant Funding Current Deferred Grant Funding Current Other income Other Nonoperating Income (Expense) Prepaid insurance expense Prepaid Insurance Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Period of insufficient cash and liquidity requirements Period of Insufficient Cash and Liquidity Requirements Period of Insufficient Cash and Liquidity Requirements Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Issuance cost on equity line paid in common stock (in shares) Stock Issued During Period, Shares, Consideration For Commitment To Purchase Shares Stock Issued During Period, Shares, Consideration For Commitment To Purchase Shares Maximum Maximum [Member] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Total liabilities Liabilities Initial payment Grants Receivable Award Type [Axis] Award Type [Axis] Granted (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Outstanding, ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Assignment Agreement Assignment Agreement [Member] Assignment Agreement [Member] Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Future Minimum Lease Payment Lessee, Operating Lease, Liability, Maturity [Table Text Block] Total stockholders' equity (deficit) Beginning balance Ending balance Stockholders' Equity Attributable to Parent Net operating loss carryforwards Operating Loss Carryforwards Common stock, shares issued (in shares) Common Stock, Shares, Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued City Area Code City Area Code Options exercisable, ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value License fees License Fee License Fee Significant Accounting Policies [Table] Significant Accounting Policies [Table] Significant accounting policies. Entity Address, City or Town Entity Address, City or Town Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Gain on extinguishment of note payable Gain on extinguishment of note payable and accrued interest Gain (Loss) on Extinguishment of Debt Receivable for expenses eligible for reimbursement Receivable For Expenses Eligible For Reimbursement Receivable For Expenses Eligible For Reimbursement Business combination shares issued (in usd per share) Business Acquisition, Share Price Stockholders' equity (deficit) Stockholders' Equity Attributable to Parent [Abstract] Note payable Notes Payable, Current Schedule of Reconciliation of the Beginning and Ending Amount of Uncertain Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Fair Value, Measurement Frequency [Domain] Measurement Frequency [Domain] Licensing Agreements Licensing Agreements [Member] Prepaid legal and professional expenses Prepaid Professional Expense Prepaid Professional Expense Health coverage to be received upon termination for cause or for good reason Employment Agreement, Health Benefits Coverage Received Upon Termination for Cause or Good Reason Employment Agreement, Health Benefits Coverage Received Upon Termination for Cause or Good Reason Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) DARE-LARC1 DARE-LARC1 [Member] DARE-LARC1 Clinical And Regulatory Milestones Clinical And Regulatory Milestones [Member] Clinical And Regulatory Milestones [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Entity Filer Category Entity Filer Category Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Exercise of Options Outstanding Exercise Of Options Outstanding [Member] Exercise of options outstanding. Income Statement [Abstract] Income Statement [Abstract] Concentration Risk [Table] Concentration Risk [Table] Entity Registrant Name Entity Registrant Name Cash and cash equivalents Convertible Debt Proceeds from the exercise of stock options Proceeds from Stock Options Exercised Related Party Transaction Related Party Transaction [Axis] Upon Reaching Certain Worldwide Net Sales Milestones Upon Reaching Certain Worldwide Net Sales Milestones [Member] Upon reaching certain worldwide net sales milestones. Forfeited (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Income tax provision Income Tax Expense (Benefit) Issuance of common stock in connection with milestone payment Stock Issued During Period, Value, Milestone Payment Stock Issued During Period, Value, Milestone Payment Amendment Flag Amendment Flag Equity Components Equity Components [Axis] Entity Tax Identification Number Entity Tax Identification Number Document Fiscal Period Focus Document Fiscal Period Focus Credits recorded to research and development expense for costs related to award Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred Total current assets Assets, Current Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Sale of Stock [Domain] Sale of Stock [Domain] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Upon Achieving Certain Development Milestones Upon Achieving Certain Development Milestones [Member] Upon Achieving Certain Development Milestones [Member] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Number of authorized shares, period increase Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) Exercise of Warrants Outstanding Exercise Of Warrants Outstanding [Member] Exercise of warrants outstanding. Stock-Based Compensation Share-based Payment Arrangement [Policy Text Block] Issuance of common stock from the exercise of warrants Adjustments to Additional Paid in Capital, Warrant Issued Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Expired (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Deferred tax assets, increase in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Maximum potential milestone payments Maximum Potential Milestone Payments Maximum Potential Milestone Payments Product and Service [Axis] Product and Service [Axis] Schedule of Common Stock Outstanding Warrant to Purchase Shares Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Proceeds from the exercise of common stock warrants Proceeds From Issuance Of Common Stock And Warrants Proceeds from issuance of common stock and warrants. Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Entity Public Float Entity Public Float Stock compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Weighted-average fair value of options granted (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Component Equity Component [Domain] MBI MBI [Member] MBI 2022 Lessee, Operating Lease, Liability, to be Paid, Year One Foreign currency translation adjustments Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Catalent and MilanaPharm Catalent and MilanaPharm [Member] Catalent and MilanaPharm Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Cash balance of financial institutions insured by federal deposits insurance corporation Cash, FDIC Insured Amount Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Potential annual license maintenance fee payments, thereafter Potential Annual License Maintenance Fee Payments, Thereafter Potential Annual License Maintenance Fee Payments, Thereafter Other Assets, Noncurrent Disclosure [Abstract] Other Assets, Noncurrent Disclosure [Abstract] Statement [Line Items] Statement [Line Items] Deferred license revenue Increase (Decrease) in Contract with Customer, Liability Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Amount Weighted- Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Other Non-Current Assets Other Assets Noncurrent Disclosure [Text Block] Other assets noncurrent disclosure. Deferred financing costs Debt Issuance Costs, Noncurrent, Net Federal Domestic Tax Authority [Member] Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Counterparty Name [Domain] Counterparty Name [Domain] Loss before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Level 2 Fair Value, Inputs, Level 2 [Member] Type of Adoption [Domain] Accounting Standards Update [Domain] Valuation allowance Deferred tax valuation allowance Deferred Tax Assets, Valuation Allowance Deferred license revenue Contract with Customer, Liability, Noncurrent Auditor Location Auditor Location Customer [Axis] Customer [Axis] Use of Estimates Use of Estimates, Policy [Policy Text Block] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Document Annual Report Document Annual Report Schedule of Stock-Based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] License agreement, notice period of termination License Agreement, Notice Period Of Termination License Agreement, Notice Period Of Termination Title of 12(b) Security Title of 12(b) Security Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Total assets Assets Expiration Date Class Of Warrant Or Rights Warrants Expiration Date Class of warrant or rights warrants expiration date. Plan Name [Domain] Plan Name [Domain] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Percentage of royalty rate Percentage Of Royalty Rate Percentage of royalty rate. Net loss to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Document Type Document Type Product and Service [Domain] Product and Service [Domain] Research and development Research and Development Expense Juniper Pharmaceuticals, Inc. Juniper Pharmaceuticals, Inc. [Member] Juniper Pharmaceuticals, Inc. [Member] Renewal term of operating lease Lessee, Operating Lease, Renewal Term Deferred financing costs Deferred Offering Costs, Unamortized Portion Deferred Offering Costs, Unamortized Portion Contingent consideration, liability Business Combination, Contingent Consideration, Liability Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Deferred grant funding Increase (Decrease) In Deferred Grant Funding Increase (Decrease) In Deferred Grant Funding Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities [Member] Payments to stockholders' representative in business combination Payments to Stockholders' Representative in Business Combination Payments to Stockholders' Representative in Business Combination Measurement Frequency [Axis] Measurement Frequency [Axis] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Research credit carryforwards Tax Credit Carryforward, Amount Subsequent Event [Line Items] Subsequent Event [Line Items] Other receivables Other Receivables, Net, Current Tax Credit Carryforward Tax Credit Carryforward [Axis] Risks and Uncertainties Risks And Uncertainties [Policy Text Block] Risks and uncertainties Net operating loss carryforwards expiration year Operating Loss Carryforwards Expiration Period Operating loss carryforwards expiration period. Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Loss per common share - diluted (in usd per share) Earnings Per Share, Diluted State State and Local Jurisdiction [Member] Current portion of contingent consideration Asset Acquisition, Contingent Consideration, Current Asset Acquisition, Contingent Consideration, Current Asset Acquisition, Contingent Consideration, Current License agreement termination periodic discontinued sale of product License Agreement Termination Periodic Discontinued Sale Of Product License Agreement Termination Periodic Discontinued Sale Of Product Project Project [Axis] Purchase Agreement Purchase Agreement [Member] Purchase Agreement Subsequent Events Subsequent Events [Text Block] Change in control of company, termination for cause or for good reason Employment Agreement, Change in Control of Company, Termination for Cause or Good Reason Employment Agreement, Change in Control of Company, Termination for Cause or Good Reason Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Weighted average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Difference Between Provision for Income Taxes (Benefit) and the Amount Computed by Applying U.S. Federal Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Accounts payable Accounts Payable, Current Concentration Risk Type [Axis] Concentration Risk Type [Axis] Issuance cost on equity paid in common stock Issuance Cost On Equity Paid In Common Stock Issuance Cost On Equity Paid In Common Stock Schedule of Financial Assets and Liabilities Remeasured on a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Notes payable including accrued interest Notes Payable, Current, Plus Accrued Interest Notes Payable, Current, Plus Accrued Interest Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] License fee to be paid upon contingency License Fee, To Be Paid Upon Contingency License Fee, To Be Paid Upon Contingency Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Supplier Concentration Risk Supplier Concentration Risk [Member] Percentage of rights to inventions by employees under license agreement Percentage Of Rights To Inventions By Employees Under License Agreement Percentage of rights to inventions by employees under license agreement. Business acquisition transaction value Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Document Period End Date Document Period End Date Entity Central Index Key Entity Central Index Key Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregate Intrinsic Value Roll Forward Share based compensation arrangement by share based payment award options outstanding aggregate intrinsic value. Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] State income tax, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Research and development credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards, Research Research credit carryforwards expiration year Tax Credit Carryforward Expiration Period Tax credit carry forward expiration period. Income Statement Location [Domain] Income Statement Location [Domain] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Vendor Concentration Concentration Risk Disclosure [Text Block] Property and equipment, net Property, Plant and Equipment, Net Total operating expenses Operating Expenses Lease liabilities long-term Other Liabilities, Noncurrent Issuance of common stock in connection with milestone (in shares) Stock Issued During Period, Shares, Milestone Payment Stock Issued During Period, Shares, Milestone Payment Audit Information [Abstract] Audit Information MilanaPharm MilanaPharm [Member] MilanaPharm [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Trading Symbol Trading Symbol Milestone payments, contingent amount payable, net Milestone Payments, Contingent Amount Payable, Net Milestone Payments, Contingent Amount Payable, Net Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Related Party Transaction Related Party Transaction [Domain] Upfront license fee paid Upfront License Fee, Amount Paid Upfront License Fee, Amount Paid Warrants Expiring On February 15, 2023 Warrants Expiring On February Fifteen Two Thousand Twenty Three [Member] Warrants Expiring On February Fifteen Two Thousand Twenty Three [Member] Exercise price (in usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Options vested and expected to vest, ending (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Outstanding beginning balance (in usd per share) Outstanding ending balance (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Research credit carryforward, subject To expiration Tax Credit Carry Forward, Subject To Expiration Tax Credit Carry Forward, Subject To Expiration Stock-based compensation expense Share-based Payment Arrangement, Expense Options exercisable, ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Research Credit Carryforwards Research Tax Credit Carryforward [Member] Entity Current Reporting Status Entity Current Reporting Status Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Grant Awards Grant Award [Text Block] Grant Award [Text Block] NICHD NICHD [Member] NICHD Counterparty Name [Axis] Counterparty Name [Axis] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] First commercial sale amount Milestone Payments, Contingent Amount, First Commercial Sale Amount Milestone Payments, Contingent Amount, First Commercial Sale Amount Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain] Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Current Assets Assets, Current [Abstract] Common stock reserved for issuance (in shares) Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Leases [Abstract] Leases [Abstract] Income Taxes Income Tax, Policy [Policy Text Block] Permanent differences Effective Income Tax Rate Reconciliation, Permanent Differences Effective income tax rate reconciliation, permanent differences. Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Entity Address, Postal Zip Code Entity Address, Postal Zip Code Schedule of Accounts Payable and Accrued Expenses Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Stock options exercised (in shares) Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Upon Achievement Of Specified Development And Regulatory Milestones Upon Achievement Of Specified Development And Regulatory Milestones [Member] Upon achievement of specified development and regulatory milestones. Income Taxes Income Tax Disclosure [Text Block] Related Party [Domain] Related Party [Domain] Summary of Stock Option Activity for 2015 Plan and Current Plan and Related Information Share-based Payment Arrangement, Option, Activity [Table Text Block] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Prepaid Expenses Other Current Assets [Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Auditor Firm ID Auditor Firm ID Operating lease discount rate Lessee, Operating Lease, Discount Rate Class of Stock [Line Items] Class of Stock [Line Items] Purchase obligation Purchase Obligation Entity Address, Address Line One Entity Address, Address Line One Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Entity Address, Address Line Two Entity Address, Address Line Two Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Estimated fair value of warrants Estimated Fair Value Of Warrants Recorded In Equity Estimated Fair Value Of Warrants Recorded In Equity Unremitted earnings Unremitted Earnings Unremitted earnings. Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] General and administrative General and Administrative Expense [Member] Principles of Consolidation Consolidation, Policy [Policy Text Block] Entity Shell Company Entity Shell Company Grant funding recognized during period Grant Funding Recognized During Period Grant Funding Recognized During Period Expected life in years Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Lincoln Park Lincoln Park [Member] Lincoln Park Total current liabilities Liabilities, Current Class of Stock [Domain] Class of Stock [Domain] Non-cash operating lease cost Non-Cash Lease Expense Non-Cash Lease Expense Defined contribution plan, employer matching contribution, percent of match Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Options vested and expected to vest, ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Asset Acquisition, Contingent Consideration, Rollforward [Abstract] Asset Acquisition, Contingent Consideration, Rollforward [Abstract] Asset Acquisition, Contingent Consideration, Rollforward Annual percentage increase in outstanding number of common stock Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum Current Fiscal Year End Date Current Fiscal Year End Date Cash flow from operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations Forfeiture rate Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate Share-based compensation arrangement by Share-based payment award fair value assumptions forfeiture rate. Statement [Table] Statement [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Summary of Common Stock Reserved for Future Issuance Schedule Of Common Stock Reserved For Future Issuance [Table Text Block] Schedule of common stock reserved for future issuance Other Deferred Tax Assets, Other Other non-current assets Increase (Decrease) in Other Noncurrent Assets Issuance cost on equity paid in common stock Stock Issued During Period, Value, Consideration For Commitment To Purchase Shares Stock Issued During Period, Value, Consideration For Commitment To Purchase Shares Statistical Measurement [Axis] Statistical Measurement [Axis] Other receivables Increase (Decrease) in Other Receivables Subsequent Event Subsequent Event [Member] Deposits Deposits Assets, Noncurrent Indemnification Obligations Guarantees, Indemnifications and Warranties Policies [Policy Text Block] ADVA Tec Agreement A D V A Tec Agreement [Member] ADVA Tec agreement. Warrant, exercise price, decrease Warrant, Exercise Price, Decrease Operating lease, right-of-use asset, statement of financial position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Accrued license expense Accrued License Expense Accrued License Expense Issuance of common stock from the exercise of warrants (in shares) Adjustments To Additional Paid In Capital, Common Stock And Warrants Issued, Shares Adjustments To Additional Paid In Capital, Common Stock And Warrants Issued, Shares April 2021 ATM Sales Agreement April 2021 At The Market Sales Agreement [Member] April 2021 At The Market Sales Agreement Grant Awards Grant [Member] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Operating lease cost Operating Lease, Cost Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Amount awarded for grant Proceeds From Award Of Grant Proceeds From Award Of Grant Organon Organon [Member] Organon Payment of additional consideration in business combination Payment of Additional Consideration in Business Combination Payment of Additional Consideration in Business Combination Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Options vested and expected to vest, ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term